Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02398149 · ClinicalTrials.gov registry record
Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis
A clinical trial of Multiple Sclerosis, sponsored by Mount Sinai Rehabilitation Hospital.
- Completed
- Registry status
- 267
- Enrollment target
- 1
- Study location
NCT02398149: Completed study of Multiple Sclerosis, sponsored by Mount Sinai Rehabilitation Hospital.
NCT02398149 is a study of Multiple Sclerosis that has completed, run by Mount Sinai Rehabilitation Hospital. The registered enrollment target is 267 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02398149, a study of Multiple Sclerosis, has completed, sponsored by Mount Sinai Rehabilitation Hospital.
- COMPLETED
- Registry status
- 267 participants
- Enrollment target
- 1
- Study location
Study Summary
Upper extremity (UE) function is critical to maintaining independence. Better understanding of UE involvement in MS will provide necessary information to prioritize the design and selection of future interventions. The goal of the proposed project is to characterize UE involvement in a population of community-based persons with MS across the International Classification of Functioning, Disability \& Health (ICF) domains and constructs.
Conditions Studied
Study Locations (1)
Connecticut
- Mandell Center for Multiple Sclerosis at the Mount Sinai Rehabilitation Hospital - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-10 |
What the finished NCT02398149 record still lists
NCT02398149 is an observational study that tracks outcomes without assigning an intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT02398149 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02398149 about?
NCT02398149 is a clinical study titled "Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis". Upper extremity (UE) function is critical to maintaining independence. Better understanding of UE involvement in MS will provide necessary information to prioritize the design and selection of future interventions. The goal of the proposed project is to characterize UE involvement in a population of...
What is the current status of trial NCT02398149?
This trial is currently completed. The enrollment target is 267 participants. The study started on 2013-10. Estimated completion is 2016-10.
What conditions does trial NCT02398149 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
Who is sponsoring clinical trial NCT02398149?
This trial is sponsored by Mount Sinai Rehabilitation Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02398149 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02398149's enrollment target sits among peer trials
267 66th of 315 higher than 250 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04997109 · 267 participants · NA
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
- NCT05355701 · 267 participants · Phase 1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- NCT06203509 · 267 participants · NA
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia